Cargando…

Peripheral neuropathy and monoclonal gammopathy of undetermined significance: a population-based study including 15,351 cases and 58,619 matched controls

Detalles Bibliográficos
Autores principales:	Rögnvaldsson, Sæmundur, Steingrímsson, Vilhjálmur, Turesson, Ingemar, Björkholm, Magnus, Landgren, Ola, Kristinsson, Sigurður Yngvi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2020
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604635/ https://www.ncbi.nlm.nih.gov/pubmed/33131261 http://dx.doi.org/10.3324/haematol.2019.239632

Ejemplares similares

History of autoimmune disease is associated with impaired survival in multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based study
por: Lindqvist, Ebba K., et al.
Publicado: (2016)

Autoimmunity, Infections, and the Risk of Monoclonal Gammopathy of Undetermined Significance
por: Sigurbergsdóttir, Aðalbjörg Ýr, et al.
Publicado: (2022)

P950: PRIOR CANCER AND RISK OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS): A POPULATION-BASED STUDY IN ICELAND AND SWEDEN
por: Rögnvaldsson, Sæmundur, et al.
Publicado: (2023)

Diabetes mellitus and risk of plasma cell and lymphoproliferative disorders in 94,579 cases and 368,348 matched controls
por: Shah, Urvi A., et al.
Publicado: (2021)

Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study
por: Rognvaldsson, Saemundur, et al.
Publicado: (2021)

Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohorts: results from the population-based iStopMM study
por: Sigurbergsdóttir, Aðalbjörg Ýr, et al.
Publicado: (2023)

P894: INFECTION RISK BEFORE DIAGNOSIS OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE: RESULTS FROM THE SCREENED POPULATION-BASED ISTOPMM STUDY
por: Ros Levy, Marina, et al.
Publicado: (2023)

Fractures and survival in multiple myeloma: results from a population-based study
por: Thorsteinsdottir, Sigrun, et al.
Publicado: (2020)

Monoclonal Gammopathy of Undetermined Significance and COVID-19: Results from the Population-Based Iceland Screens Treats or Prevents Multiple Myeloma Study (iStopMM)
por: Rögnvaldsson, Sæmundur, et al.
Publicado: (2021)

Incidence of multiple myeloma in Great Britain, Sweden, and Malmö, Sweden: the impact of differences in case ascertainment on observed incidence trends
por: Vélez, Ramón, et al.
Publicado: (2016)

Sars-Cov-2 Vaccinations Do Not Lead to Progression of Monoclonal Gammopathy of Undetermined Significance: Results from the Population-Based Istopmm Screening Study
por: Palmason, Robert, et al.
Publicado: (2022)

Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies
por: Rögnvaldsson, Sæmundur, et al.
Publicado: (2021)

Correction: Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies
por: Rögnvaldsson, Sæmundur, et al.
Publicado: (2023)

Immunophenotypic studies of monoclonal gammopathy of undetermined significance
por: Olteanu, Horatiu, et al.
Publicado: (2008)

Monoclonal Gammopathy of Undetermined Significance-associated Scleromyxoedema
por: Baxi, Kalgi D., et al.
Publicado: (2019)

Kidney Transplantation and Monoclonal Gammopathy of Undetermined Significance
por: Aslam, Nabeel, et al.
Publicado: (2021)

P900: INVOLVED/UNINVOLVED SERUM FREE LIGHT CHAIN RATIO IS A STRONGER PREDICTOR OF DIAGNOSTIC/RISK FACTORS IN LIGHT CHAIN COMPARED TO HEAVY CHAIN MONOCLONAL GAMMOPATHIES
por: Thorir Oskarsson, Jon, et al.
Publicado: (2023)

Germline and somatic JAK2 mutations and susceptibility to chronic myeloproliferative neoplasms
por: Goldin, Lynn R, et al.
Publicado: (2009)

Are neurological complications of monoclonal gammopathy of undetermined significance underestimated?
por: Steiner, Normann, et al.
Publicado: (2016)

Association of Pulmonary Hypertension and Monoclonal Gammopathy of Undetermined Significance
por: Lyle, Melissa A., et al.
Publicado: (2022)

Monoclonal Gammopathy of Undetermined Significance Disguised as Chronic Neutrophilic Leukemia
por: Hartley, M.A., et al.
Publicado: (2010)

Aspergillus fumigatus Scleritis Associated with Monoclonal Gammopathy of Undetermined Significance
por: Jo, Dong Hyun, et al.
Publicado: (2010)

Advances in the understanding of IgM monoclonal gammopathy of undetermined significance
por: Paludo, Jonas, et al.
Publicado: (2017)

Contributions of the Bone Microenvironment to Monoclonal Gammopathy of Undetermined Significance Pathogenesis
por: Gámez, Beatriz, et al.
Publicado: (2018)

Necrotising fasciitis in a patient with monoclonal gammopathy of undetermined significance
por: Vella, John X., et al.
Publicado: (2019)

The Evolution of Monoclonal Gammopathy of Undetermined Significance in Kidney Transplant Recipients
por: Gagnon, Marie-France, et al.
Publicado: (2019)

Gamma-heavy chain monoclonal gammopathy with undetermined significance (MGUS)
por: Zushi, Yuriko, et al.
Publicado: (2019)

Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS)
por: Pang, Li, et al.
Publicado: (2021)

Cardiovascular Associations With Monoclonal Gammopathy of Undetermined Significance: Real or Coincidental?
por: Kapoor, Prashant, et al.
Publicado: (2022)

Lifetime Pesticide Use and Monoclonal Gammopathy of Undetermined Significance in a Prospective Cohort of Male Farmers
por: Hofmann, Jonathan N., et al.
Publicado: (2021)

A Case of Cardiac Dysfunction Associated with Monoclonal Gammopathy of Undetermined Significance
por: Jang, Suk-Tae, et al.
Publicado: (2009)

A Case of Crystalline Keratopathy in Monoclonal Gammopathy of Undetermined Significance (MGUS)
por: Koo, Hyun, et al.
Publicado: (2011)

Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance()
por: Shimanovsky, Alexei, et al.
Publicado: (2016)

Monoclonal gammopathy of undetermined significance: a contraindication for living kidney donation?
por: Serra, Nuria, et al.
Publicado: (2011)

Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All
por: Lomas, Oliver C., et al.
Publicado: (2020)

Intraosseous schwannoma of the femur in a patient with monoclonal gammopathy of undetermined significance
por: McAleese, Timothy, et al.
Publicado: (2020)

THE ROLE OF A MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE DIAGNOSIS IN HEALTHCARE UTILIZATION
por: Castaneda-Avila, Maira, et al.
Publicado: (2022)

Identifying monoclonal gammopathy of undetermined significance from electronic health records
por: Tanenbaum, Hilary C., et al.
Publicado: (2022)

Monoclonal gammopathy of undetermined significance: evaluation, risk assessment, management, and beyond
por: Abeykoon, Jithma P, et al.
Publicado: (2022)

The “Undetermined Significance” of (18)F-FDG PET/CT or PET/MRI in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)
por: Treglia, Giorgio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0uadk2eokn8v4ku2mc8ihamfgm